skip to Main Content
An Insightful Solution for Women’s Healthcare
Novaplex™ HPV28 Detection and HPV HR

19 High-risk HPVs screening | 28 HPVs genotyping

43
million

HPV (the virus): CDC estimates that there were 43 million HPV infections in 2018. In that same year, there were 13 million new infections. HPV is so common that almost every sexually active person will contract HPV at some point if they don’t get vaccinated.1

Understanding HPV

Human papillomavirus (HPV) is known to be the leading cause of cervical cancer in women. Although more than 200 HPV types have been identified, only certain types, such as 16 and 18, are major risk factors for cervical cancer. It has recently been recognized that co-infection of high-risk and low-risk HPV affects cancer severity and progression.2 In addition, long-term monitoring studies are showing the benefits from HPV vaccination.

HPV can cause cervical and other cancers, including cancer of the vulva, vagina, penis, or anus. It can also cause cancer in the back of the throat (oropharyngeal cancer). This can include the base of the tongue and tonsils. Cancer often takes years, even decades, to develop after a person gets HPV. In most cases (9 out of 10), HPV goes away on its own within two years without any health problems. But when HPV does not go away, it can cause health problems like genital warts and cancer. Genital warts and cancers result from different types of HPV.

Cervical cancer: Every year, nearly 12,000 women living in the U.S. will have cervical cancer. More than 4,000 women die per year from cervical cancer.

Novaplex™ HPV28 Detection* are designed to identify 19 high risk and/or 28 unique low and high-risk HPV types in a single specimen including those that are known to cause cervical cancer.

Novaplex™ HPV HR Detection* is suitable for HPV detection in all circumstances, meeting diverse region-specific identification needs. It allows more efficient turnaround time and fully automated workflow and is designed to provide comprehensive information.

*All Novaplex™ products are for Research Use Only. Not for use in diagnostic procedures.

Product Information
Analytes
Novaplex™ HPV28 Detection

HPV16
HPV18
HPV26
HPV31
HPV33
HPV35
HPV39

HPV45
HPV51
HPV52
HPV53
HPV56
HPV58
HPV59

HPV66
HPV68
HPV69
HPV73
HPV82

HPV6
HPV11
HPV40

HPV42
HPV43
HPV44

HPV54
HPV61
HPV70

Novaplex™ HPV HR Detection

HPV66
HPV51
HPV33
HPV56

HPV45
HPV59
HPV39
HPV35
HPV68

HPV58
HPV16
HPV52
HPV18
HPV31

Specimen

Cervical sample
Self-collected vaginal sample

Compatible instrumentation

Automated Extraction & PCR Setup
Seegene NIMBUS
Seegene STARlet

Real-time PCR
CFX96™ Real-time PCR Detection System (Bio-Rad)
CFX96™ Dx (Bio-Rad)
CFX96™ Touch (Bio-Rad)
CFX96™ Opus (Bio-Rad)

Seegene Viewer Software

  • Quick and easy data analysis and interpretation
  • Interface specialized for multiplex testing
Key Features
  • Genotyping of 28 HPV types in a single reaction
  • Multiplex real-time PCR with high sensitivity and specificity by utilization of DPO™ and TOCE™ technologies
  • Internal Control as an endogenous whole process control in order to monitor nucleic acid isolation and check for PCR inhibition
  • HPV analysis by cyclic-CMTA (Catcher Melting Temperature Analysis)
  • Comprehensive individual genotype results and Ct values in a single test
Ordering Information

Select the assays you are interested in and a Seegene representative will contact you to complete your order.

Product
Product
1 STD Facts - Human papillomavirus (HPV). Centers for Disease Control and Prevention. (2022). Retrieved from https://www.cdc.gov/std/hpv/stdfact-hpv.htm
2 Burd E. M. (2003). Human papillomavirus and cervical cancer. Clinical microbiology reviews16(1), 1–17. https://doi.org/10.1128/CMR.16.1.1-17.2003 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC145302/#
Back To Top